Omron (OTCMKTS:OMRNY) Stock Price Up 23.7% – Still a Buy?

Omron Corp. (OTCMKTS:OMRNYGet Free Report) was up 23.7% on Monday . The stock traded as high as $31.51 and last traded at $31.51. Approximately 1,303 shares were traded during trading, a decline of 97% from the average daily volume of 45,504 shares. The stock had previously closed at $25.4750.

Analyst Ratings Changes

Separately, Zacks Research raised Omron from a “strong sell” rating to a “hold” rating in a research report on Monday, January 19th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold”.

Get Our Latest Stock Analysis on Omron

Omron Stock Performance

The firm has a 50-day simple moving average of $25.87 and a two-hundred day simple moving average of $26.46. The company has a current ratio of 2.14, a quick ratio of 1.40 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $6.57 billion, a price-to-earnings ratio of 40.35, a price-to-earnings-growth ratio of 0.64 and a beta of 0.98.

Omron (OTCMKTS:OMRNYGet Free Report) last announced its quarterly earnings results on Thursday, February 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.19). The firm had revenue of $1.41 billion during the quarter, compared to the consensus estimate of $1.38 billion. Omron had a net margin of 2.80% and a return on equity of 2.46%. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. As a group, sell-side analysts forecast that Omron Corp. will post 0.42 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Omron

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC boosted its position in shares of Omron Corp. (OTCMKTS:OMRNYFree Report) by 50.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,129 shares of the company’s stock after acquiring an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 1.09% of the company’s stock.

Omron Company Profile

(Get Free Report)

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.

Featured Articles

Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.